Simple Bedside Predictors of Survival after Percutaneous Gastrostomy Tube Insertion.
Journal
Canadian journal of gastroenterology & hepatology
ISSN: 2291-2797
Titre abrégé: Can J Gastroenterol Hepatol
Pays: Egypt
ID NLM: 101623613
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
07
2019
revised:
26
09
2019
accepted:
31
10
2019
entrez:
13
12
2019
pubmed:
13
12
2019
medline:
30
5
2020
Statut:
epublish
Résumé
Percutaneous endoscopic gastrostomy (PEG) tube insertion is an increasingly used minimally invasive method for long-term enteral feeding. Identification of simple predictors for short-term mortality (up to one month) after PEG insertion is of paramount importance. We aimed to explore a simple noninvasive parameter that would predict survival following PEG insertion. We performed a retrospective study of all patients who underwent PEG insertion at the Galilee Medical Center from January 1, 2014 to December 30, 2018. We collected simple clinical and laboratory parameters and survival data and looked for predictors of short-term mortality. A total of 272 patients who underwent PEG insertion were included. Sixty-four patients (23.5%) died within one month after PEG insertion compared to 208 patients (76.5%) who survived for more than one month. Univariate analysis revealed several short-term mortality-related predictors, including older age (OR 1.1, We could identify several simple parameters associated with high risk of mortality, and we recommend considering using these parameters in decision-making regarding PEG insertion. Further prospective studies are needed to validate our findings.
Sections du résumé
Background
Percutaneous endoscopic gastrostomy (PEG) tube insertion is an increasingly used minimally invasive method for long-term enteral feeding. Identification of simple predictors for short-term mortality (up to one month) after PEG insertion is of paramount importance.
Aim
We aimed to explore a simple noninvasive parameter that would predict survival following PEG insertion.
Methods
We performed a retrospective study of all patients who underwent PEG insertion at the Galilee Medical Center from January 1, 2014 to December 30, 2018. We collected simple clinical and laboratory parameters and survival data and looked for predictors of short-term mortality.
Results
A total of 272 patients who underwent PEG insertion were included. Sixty-four patients (23.5%) died within one month after PEG insertion compared to 208 patients (76.5%) who survived for more than one month. Univariate analysis revealed several short-term mortality-related predictors, including older age (OR 1.1,
Conclusion
We could identify several simple parameters associated with high risk of mortality, and we recommend considering using these parameters in decision-making regarding PEG insertion. Further prospective studies are needed to validate our findings.
Identifiants
pubmed: 31828049
doi: 10.1155/2019/1532918
pmc: PMC6881763
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1532918Informations de copyright
Copyright © 2019 Wisam Sbeit et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest or funding sources to disclose.
Références
JPEN J Parenter Enteral Nutr. 1997 Mar-Apr;21(2):72-4
pubmed: 9084008
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618824418
pubmed: 30808220
Ann Gastroenterol. 2014;27(1):42-47
pubmed: 24714451
Clin Nutr ESPEN. 2016 Aug;14:19-23
pubmed: 28531394
J Gen Intern Med. 1996 May;11(5):287-93
pubmed: 8725977
Gastrointest Endosc. 2011 Jan;73(1):29-36
pubmed: 21074760
Gastroenterology. 1995 Apr;108(4):1282-301
pubmed: 7698596
Endoscopy. 2004 Jun;36(6):522-6
pubmed: 15202049
JAMA. 1998 Jun 24;279(24):1973-6
pubmed: 9643861
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1437-1444.e3
pubmed: 23602822
Gastroenterology. 1987 Jul;93(1):48-52
pubmed: 3108063
J Gen Intern Med. 1992 Jan-Feb;7(1):46-51
pubmed: 1548547
Aging Clin Exp Res. 2016 Oct;28(5):983-9
pubmed: 26582081
Clin Nutr. 2005 Oct;24(5):848-61
pubmed: 16261664
Urol Oncol. 2019 Nov;37(11):812.e1-812.e8
pubmed: 31053528
J Clin Gastroenterol. 2017 Apr;51(4):339-344
pubmed: 27479141
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):424-430
pubmed: 28823374
Intest Res. 2016 Oct;14(4):333-342
pubmed: 27799884
Harefuah. 2008 Jun;147(6):500-3, 575
pubmed: 18693625
Scand J Gastroenterol. 2019 Apr;54(4):513-518
pubmed: 30905223
JAMA. 2006 Feb 15;295(7):801-8
pubmed: 16478903
Scand J Gastroenterol. 2012 Jun;47(6):737-42
pubmed: 22471958